Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Correction in Gold Stocks Continues

Several weeks ago both Gold and gold stocks hit major resistance after strong but extended moves. A correction or pause was to be expected. Clearly, we can now say, the sector is in correction mode. Corrections tend to have three legs: a simple down up down or A-B-C patter...
Jordan Roy-Byrne, CMT | October 1, 2019 |

China’s Actions to Jumpstart a New Industrial Sector in US & Canada

Byron King, Managing Editor The Fire Bell Is Ringing! Hi Byron, ...
Featured Submission | July 21, 2020 |

From a Failed Breakout to a Failed Breakdown

The historical action of the precious metals sector over the past few weeks has continued. The strong recovery in GDX, GDXJ, and Silver has potentially invalidated the technical breakdown that occurred during the crash. It appears to be a failed breakdown. Furthermor...
Jordan Roy-Byrne, CMT | March 30, 2020 |

Is Gold Price Action Warning Of Imminent Monetary Collapse?

During the 2008 financial crisis the Fed significantly increased the US monetary base to keep the system from collapse. They are currently in a similar situation, and have done (is doing) the exact same thing. Here is a chart of the US monetary base to illustrate the simi...
Hubert Moolman | April 22, 2020 |

The Central Banks Are Preparing and So Should We

https://soundcloud.com/proven-and-probable/the-central-banks-are-preparing-and-so-should-we Andy Schectman the President of Miles Franklin Precious Metals Investments sits down with Maurice Jackson of Proven and Probable to discuss how central banks are de-dol...
Maurice Jackson | February 5, 2020 |

After Financing Close, Biotech's Subsidiary to Operate Independently

An H.C. Wainwright & Co. report explained the purpose of the funding and how any resulting developments would positively impact the former parent company. In a Feb. 22 research report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals In...
Streetwise Reports | March 6, 2019 |

HYRE Pads Balance Sheet

Last week, HyreCar (HYRE:NASDAQ) sold shares at $3. I have to admit, this came as a total surprise to me. With HyreCar going cash-flow neutral in the second quarter, I had been operating under the assumption that they wouldn't need to raise money anytime soon. Turns out...
Streetwise Reports | July 26, 2019 |

We Should Let the Banks Burn Down

Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail. In later 2008 during what is now referred to as the Great Financial Crisis, government and financial managers had an opportunity to reset a badly out of balance banking system....
Streetwise Reports | August 7, 2019 |

Fibrocell Science Shares Rise 60% on Acquisition News

Fibrocell Science's shares are trading up 60% today after the company announced that it agreed to be acquired by Castle Creek Holdings for $63.3 million, or $3.00 per share. Cell and gene therapy company Fibrocell Science Inc. (FCSC:NASDAQ) , which focuses on transfo...
Streetwise Reports | September 16, 2019 |

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53. Yesterday evening,...
Streetwise Reports | December 16, 2019 |
1 2 3 4 5 6 7 8 9 10 ...